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Objectives: To review outcomes and complications of endoscope-assisted submandibu-
larsialadenectomy(EASS)andtoanalyzethisinnovativetechniquewithregardtoethical
issues.Methods:Weusedasystematicreviewstudydesigntoidentifyclinicalstudieson
EASS, published in English, French, German, and Thai. The last electronic search was
conducted in September 2009. We checked the bibliographies of the identiﬁed articles,
relevant local journals, and congress abstracts. Publications were further assessed and
assigned their respective levels of evidence. We also investigated reporting on human
subject protection, conﬂicts of interest, funding support, and commercial relationships.
Results: Five case series reporting a total of 28 patients met the inclusion criteria.
There was no need of recourse to open surgery. All of the authors claimed satisfac-
tory cosmetic results. Complications were uncommon. However, no controlled trial was
available, and outcome measures varied between studies. Human subject protection and
funding sources were mentioned in only 2 articles. Commercial relationships and con-
ﬂicts of interest could not be identiﬁed. Conclusions: All of the reports favor outcomes
of EASS. However, their level of evidence is low, and the superiority of this procedure
over the conventional surgery remains unknown. The success of this procedure should
∗ Both authors are equally contributed.
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not be overemphasized in information for consent and mislead surgeons to begin it
without adequate training and elaborate environment. The lack of ethical documentation
creates a high degree of suspicion of the studies.
Informed consent becomes important in current medical practice. Clinical decision
making without patient participation is considered unethical and, probably, illegal. Inade-
quate patient consent may lead to discontent and lawsuits. Of several aspects of consent,
the risks of the procedure are necessary to be informed preoperatively. In general, surgeons
discuss speciﬁc and common complications of surgery based on their own experience.
However, the consent process is cumbersome when a surgeon begins a new procedure or
innovation or is unfamiliar with a novel intervention.1
Even though neoplasia constitutes a small proportion of submandibular salivary gland
diseases,itsconsequencesaredevastating.Surgeryisthedeﬁnitivetreatmentofamajorityof
submandibularsalivaryglandtumors.Conventionalopenoperationsatisﬁesmostcases,but
it carries various risks, including conspicuous scar, injury to facial, lingual and hypoglossal
nerves, infection, ﬁbrosis, and hemorrhage.2-4
In 1990, endoscopy was initially used in intracorporeal lithotripsy of salivary calculi
by K¨ onigsbergeretal.5 Sincethen,ithasbeenintroducedintheﬁeldsofcraniomaxillofacial
and facial plastic surgery. Several advantages are documented, especially decreased tissue
damageandsurgicalcomplications,improvedestheticresults,andfastrecovery.6-8 Basedon
the ﬁrst author (P.P.)’s experience, endoscopy is applicable very well to various procedures,
includingrepairoforbitalwallfractures,9,10 excisionofthesubmandibularsalivarygland,11
and lipomas on the forehead.12 Endoscopic removal of dermoid cysts of the neck requires
much training and delicate skill (unpublished yet). Nowadays endoscopy is an adjunct
in submandibular sialadenectomy in many surgical centers. Nevertheless, outcomes and
complications of endoscope-assisted submandibular sialadenectomy (EASS) have not been
studied by an evidence-based approach.
The aims of this article were to review reported outcomes and complications of
EASS to be part of information for consent. We hypothesized that this novel technique
would provide better outcomes and fewer complications than conventional surgery. This
evidence-based information will be a supplement to personal data of an individual surgeon.
The secondary aim was to analyze this innovative surgery with regard to ethical issues.
Ethical considerations on EASS are also discussed.
METHODS
Using a systematic review study design, we searched the Cochrane library,
PubMed/MEDLINE, Embase, and Google Scholar, using the search terms: “salivary gland
tumor,” “submandibular gland,” “endoscope,” and “sialadenectomy.” Full-length articles
in English, French, German, and Thai published until September 2009 were screened to
identify clinical studies on EASS. References of the selected articles, relevant local jour-
nals, and congress abstracts were reviewed to identify additional reports for inclusion. We
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rejected (1) studies with a follow-up period of less than 6 months and (2) studies based on
postal questionnaire or case note reviews without postoperative examination.
All included articles were classiﬁed on the basis of the grading system adopted by the
JournalofBoneandJointSurgery13 (Table1).EvaluationofthearticlesinFrench,German,
and Thai was assured by the native language–speaking authors. Level categorization and
datacollectionwereperformedbytheprimaryauthor(P.P.),anduncertaintieswereresolved
by discussion with all authors. If agreement could not be reached, advice was sought from
a third party.
Table 1. Levels of evidence adopted by the Journal of Bone and Joint
Surgery for therapeutic studies13
Level I Randomized controlled trial (RCT) with statisti-
cally signiﬁcant difference or no signiﬁcant differ-
ence, but narrow, conﬁdence intervals
Systemic review of Level I RCTs
Level II Prospective cohort study, or poor quality RCT
(eg, <80% follow-up)
Systematic review of Level II studies
Level III Case control study
Retrospective cohort studies
Systematic review of Level III studies
Level IV Case series (no, or historical, control group)
Level V Expert opinion
Non-evidence Single-case reports
Technical notes
Animal or laboratory studies
Nonsystematic reviews
The methodology to identify secondary outcomes of this study was based on our
previous research designs.14-16 One secondary outcome was author’s statements on human
subject protection (obtaining informed consent and ethics committee’s approval) and con-
ﬂicts of interest in all eligible articles. Reporting of human subject protection was justiﬁed,
if both processes (obtaining inform consent and ethical approval) were mentioned, or au-
thors explained why one or both were unnecessary. When there was no ethical committee
available (as in some developing countries) and a statement of adherence to international
research standards (eg, the Declaration of Helsinki) was made, the ethical documentation
was considered to be strict.
Another secondary outcome measure was funding sources of the research. Lastly, we
investigated the disclosed author-sponsor relationships, which were tabulated as follows:
advisory board, consultant/honoraria, educational activities/speakers, employment, grants,
familyconnection,experttestimony,patent/licensesandstockownership.Authorswhohad
an industry address were categorized as employees.
The recommendations of the Declaration of Helsinki were thoroughly maintained
during this study. Because this study did not involve human participants or records, it was
exemptfromthereviewbytheethicscommitteeandconsentfromtheauthorsoftheoriginal
articles. Data were summarized and evaluated by means of descriptive statistics.
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RESULTS
Five articles were identiﬁed and classiﬁed in Level IV . The number of cases and length of
follow-up were limited in most series. In total, 28 patients underwent EASS without the
need of recourse to open means, and complications were uncommon. Zero degree and/or
30◦, 4- or 5-mm rigid endoscopes were used. There was no study compared EASS with
the conventional operations. Esthetic outcomes were all judged by the innovator authors.
Neither an independent outcome assessor nor measure indices of minimally invasive proce-
dures (eg, postoperative pain and surgical blood loss) was mentioned. Details are presented
in Table 2.
In 2 articles, the patients were informed that EASS was an experiment, and funding
sourceswerenonproﬁtorganizations.Humansubjectprotection,grantsupport,andconﬂicts
of interest were not disclosed in the other 3 reports. Commercial relationships could not be
identiﬁed.
REVIEW OF LITERATURE
Conventional and endoscopic submandibular salivary gland surgeries
Submandibular sialadenectomy is indicated in cases of tumors, persistent or refrac-
tory sialadenitis, proximally located or intraparenchymal sialolithiasis, and intractable
drooling.11,17,18,21,22 Conventional transcervical surgery provides not only good direct ex-
posure to facilitate safe dissection and a quick operation but possible complications such as
visible scar, nerve injury, hematoma, and infection.2-4,20 To minimize the morbidity, other
surgical approaches have been adopted. Submandibular salivary gland resection via an
intraoral approach yields promising outcomes. However, it increases the risks of a ranula,
salivary ﬁstula, postoperative infection, lingual nerve injury, scar contracture, and subse-
quent limitation of tongue movement.22-25 A recent randomized controlled trial revealed
the success of submandibular salivary gland excision through a submental approach.4
Minimally invasive EASS is another option that shows the most promise. The incision
length is reduced from 3 to 6 cm in conventional surgery to 1.5 to 2 cm in EASS. The
submandibular gland can be extirpated in one piece through the surgical wound.11,17,18
Although valid measures were not applied, all of the eureka authors claimed satisfactory
cosmetic results.11,17-20 Good esthetic outcomes may result from minimal stretching or
compressionofsurroundingtissuesandfullexposureoftheglandduringtheprocedure.18,26
A magniﬁed view of the endoscope enables surgeons to identify and perform metic-
ulous ligatures or diathermy of important structures around the submandibular salivary
gland.Injurytoneurovascularstructurescanbeminimized.11,17,18 Differentdevices,includ-
ing a bayonet-type bipolar cautery device,18 an ultrasonically activated scalpel (Harmonic
Scalpel
R , Ethicon, NJ, U.S.A.),17,20 or a sheath retractor of the endoscope itself with the
aid of endoscopic scissors,11 can be used to free the gland. Technical reﬁnement of EASS
based on the ﬁrst author’s experience is described in previous publication.11 When indi-
cated, computed tomography or magnetic resonance imaging and/or ﬁne-needle aspiration
cytology examination of the submandibular salivary gland are made preoperatively.11,16,19
Video records of the procedure are useful for pedagogic purposes.11,26
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The primary tumor of the submandibular salivary gland is almost exclusively pleo-
morphic adenoma. The slowly expanding tumor attenuates and compresses circumferential
tissue of the gland. This normal tissue forms a pseudocapsule around the adenoma,3,27-29
creating an avascular plane superﬁcial to the gland during the dissection.22,26 It should
be borne in mind that the pseudocapsule is often incomplete, and pseudopenetration or
satellitosis of the tumor is very common.11,27-29 Intraoperative spillage of tumor mucoid
causes recurrence of the disease.20,27,29 Therefore, subcapsular dissection that facilitates
the ease of the procedure is not desirable in the EASS of pleomorphic adenoma.11,26,29 If
the intraoperative capsular rupture occurs, long-term follow-up is recommended because
of the higher recurrence rate.29,30
The important drawback of EASS is prolonged operating time. However, a steep
learning curve allows surgeons to overcome the technical difﬁculties and would shorter the
procedure duration.11,17,18,20,22,26 EASS is not suitable for malignant tumors that require
neck dissection. When the submandibular gland is inﬂamed, the EASS schedule should be
postponed.11,22,26
Human subject protection and innovative surgery
Minimally invasive surgery requires adequate training and delicate skill of the surgeons.
Formal education with exercises in laboratory, animal or cadaveric models, is necessary
before commencing an innovative surgery in humans.22 Our recent study and a Cochrane
review revealed that articles with positive results received priority in the publication.16,31
The publication bias may make an innovation more glamorous and mislead surgeons to
begin EASS without adequate training and elaborate environment. As Clark32 reminds us,
surgeon’s decision to treat can be biased by career self-interest and ﬁnancial gains. Patients
may form an innovative alliance by encouraging their surgeons to try any new thing to
improve the quality of life or prospects for survival. Meanwhile, surgeons may also be
eager to apply that innovation for the same reasons.32
AnendoscopeusedintheEASSisakintothatinparanasalsinussurgery.17,18 However,
this does not mean that the endoscopy can be applied to other parts of the human body
withoutrisksofdamage.Quiteclearly,theantralanatomygreatlydiffersfromtheanatomical
complexity of the submandibular triangle. Even in endoscopic surgery of an organ of the
neck, its details diverse from those of other organs of the neck.26,33 No studies on EASS
mentioned ethical approval. The critical questions evolve: “Is a modiﬁcation of a surgical
technique a research?” “Does it require human subject protection?” and “What and how
should a surgeon inform the patient?”
Governing bodies such as the US Food and Drug Administration regulate only ex-
periments on drugs and medical devices and products, but not reports of a new surgical
concept or technique. The boundary between minor modiﬁcations and more prominent or
extensive alterations of a surgical technique is usually unclear. Case series can therefore be
unrecognized as research until they are presented or published.34-36
Margo36 deﬁnes informal research as a case series that provides clinical parameters
and routine follow-up data as study outcomes without a written protocol. It may encompass
nomorethanaplaceboeffectandmaybecostly,time-consuming,anddangeroustohumans.
Satisfactory preliminary results can mislead one to add more patients to a study, while risks
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areinvisibleuntilthesamplesizeislargeenough.36 Innovativesurgeryispersonallyspeciﬁc
because it usually comes from talented innovators in a well-equipped environment.35-38 In
thisway,ajournalwouldbecomethemediaofharmtohumanswhenitdistributesdangerto
other surgeons who lack proper training and equipment.35,36,38 Hence, technical weakness,
a degree of safety and efﬁcacy, and factors affecting the learning curve are of great concern
when an innovation is introduced.35,36
Several factors are associated with informal research: ill-deﬁned distinction between
a technical variation and an innovation, paternalistic behavior of surgeons, careless re-
search practice, conﬂicts of interest, and lack of knowledge about research ethics and
federal requirements.35,36,39 The US National Commission for the Protection of Human
Subjects of Biomedical and Behavioral Research deﬁnes the research’s objectives as “to
test a hypothesis, permit conclusions to be drawn, and thereby to develop or contribute to
generalize knowledge.”36(p41) Therefore, a case series is considered as a subset of human
research, necessitating the strict adherence to the ethical requirements and peer review.40,41
In 1964, the Declaration of Helsinki was adopted after the World Medical Associa-
tion meeting in Helsinki, Finland and has been amended several times (the 7th revision in
2008). It clearly requires human subject protection. The World Medical Association also
invited everyone who designs, conducts, and analyzes research to adopt the Declaration
of Helsinki.42-44 The CONSORT (Consolidated Standards of Reporting Trials) statement
does not cover human subject protection. However, the Declaration of Helsinki, the recom-
mendations by the International Committee of Medical Journal Editors,World Association
of Medical Editors, Committee on Publication Ethics, International Ethical Guidelines for
Biomedical Research involving Human Subjects of the Council for International Organiza-
tions of Medical Sciences of the World Health Organization, and in the United States, the
Federal Policy for the Protection of Human Subjects (commonly known as the “Common
Rule”) do so.14,43 In France, according to the French laws (loi n◦2002-302 du 4 mars 2002;
loin◦ 2004-806 du9aoˆ ut2004),allprospectivestudies(withtheexceptionofobservational
studies) and research dealing with human tissue (other than for diagnostic and therapeutic
purposes) require ethical approval before beginning the projects. Authors must report ethi-
cal processes even if their researches are exempted or waived from the ethical review.14,45
Surprisingly, an EASS study from France in an oral-maxillofacial surgery journal did not
mention human subject protection. This supports our previous study’s ﬁnding that report-
ing of human subject protection in oral-maxillofacial surgery researches was less than
ideal.14
It is prudent to obtain human subject protection if presentation or publication is
expected and there is no exemption from local or national regulations.40,41 Exemption
from ethical approval should be decided by the regulatory body or ethical committee, not
by researchers themselves, and it should be described in the publication.14,40,41 Failure
to maintain human subject protection is ethically unacceptable and regarded as research
misconduct.46
Research involving humans must not be mixed with routine practice and then later
reported as a retrospective study. Physicians frequently take on a dual role as investigators:
physicians serve the best interests of their patients, but investigators seek truth. These 2
goalsarenotalwayscompatible.44,45 Informedconsentisnotallthesame,althoughthesame
terminology is used. Clinical consent is information about study results that are standard
in the medical community. In research practice, consent describes the hypothesis, methods,
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and outcomes of a study that may be somewhat unknown. It is therefore challenging for a
physician-scientist.34-36,39,45 To appropriately differentiate between the physician’s role as
a clinician and an investigator, the American Medical Association advises that consent be
obtained by someone other than the would-be innovator.47
Patient consent to EASS
As a general rule, patient’s permission given under “unfair” or “undue” pressure is not
consent.1 During the consent process to EASS, the surgeon must be aware of selective
hearing; patients take all information about potential beneﬁts and ﬁlter out all information
about potential risks.32 The success of the EASS should not be overemphasized, and
the surgeon should be risk-averse. Information about the risk/beneﬁt and the standard
treatments or alternatives is of paramount importance. However, when a surgeon begins
a new procedure, details of the risks and surgical complications are usually uncertain,
hampering the consent procedure. Therefore, appropriate data collection from the literature
and personal experiences becomes essential.
Because controlled studies are absent, it is impossible to prove the superiority of
EASS. The risks of complications may not differ from conventional sialadenectomy, except
smaller scars. Hence, EASS seems to be only an option for the selected cases such as in
Blacks because of a high incidence of a hypertrophic scar and keloid.48 Well-designed
studies based on more patients and cost-beneﬁt analyses are still desirable.
EASS candidates should be informed about intraoperative conversion to open explo-
ration in cases of severe adhesion, massive hemorrhage, or frozen section biopsy results
indicating malignancy.17,18,22,26 If insufﬂation of the subplatysmal region is performed,
additional risks include injury to neurovascular structures, subcutaneous emphysema, air
embolization, carotid artery occlusion, tension pneumothorax, hypercapnea, and increased
intracranial pressure.8,33
Conﬂicts of interest and clinical surgical research
Concerns about “unduly” inﬂuence of conﬂicts of interest and academic-industry sponsor-
ships on biomedical research are strikingly increasing.47,49 Conﬂicts of interest may lead to
inappropriatedesign,conduct,or reporting of research. They threatenscientiﬁcintegrityby
yielding biased study design (eg, inactivating placebo controls) and positive (pro-industry)
conclusions, suppressing studies with negative results (denial of access to research results,
data holding, publication delay or restrictions), and thus, undermine patient safety and pub-
lic trust.47,50,51 Financial interests are continuing unabated in a large proportion of medical
research and are involved in higher rates of research citations.47
Financial interests can be found in individual researchers,47,51 departmental chairs,52
ethical committee members,53 editors, and peer-reviewers.49 In the United States, the Na-
tional Institutes of Health and the Food and Drug Administration require that investigators
disclose all signiﬁcant ﬁnancial interests that affect research.47 This is in agreement with
the International Committee of Medical Journal Editors, World Association of Medical Ed-
itors, Committee on Publication Ethics, American Medical Association, and Association
of American Medical Colleges. Despite no industry involvement, conﬂicts of interest must
be disclosed.47,49,51-53
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Commercialism in the EASS studies may occur because of expensive equipment. Our
results revealed that the rates of funding and conﬂicts of interest disclosures were low
and failed to evaluate an industrial effect on study outcomes. The possible explanation is
that more than 70% of drug trials are funded by industry, while fewer surgical studies have
ﬁnancialsupport.50 Researchfundedmostlybythegovernment,universities,orprofessional
organizationsrarelydisclosesconﬂictsofinterest.38 Thelackofethicaldocumentationmay
result from the incomplete ethical guidance in the instruction to authors of journals in
oral-maxillofacial surgery, plastic surgery, and otolaryngology.54 Our recent survey (as yet
unpublished) revealed the vast differences in understanding of the research ethics standards
among surgical paper authors. Authors may misunderstand research ethics standards, but
journals should not ignore this important issue. The credibility of the medical literature
requires transparency, not secrecy.49
Study limitations
We are aware of several limitations. First, although we used several searches, our review
did not include articles published in other languages than English, French, German, and
Thai, or articles in journals not listed by the 4 search engines we used or manuscripts
rejected for publication. This might underestimate the number of publications. Second, we
did not investigate the actual processes that authors performed human subject protection
and used to manage conﬂicts of interest. The use of an external observer, albeit impractical,
would be more accurateto analyzethe actualpractice.Third, reporting of human subjection
protection and conﬂicts of interest might be absent because authors did not disclose them
or because journals did not publish them.
CONCLUSION
Endoscope-assisted submandibular sialadenectomy (EASS) offers a good surgical view
through a minimal cutaneous incision. However, the published studies offer weak evidence.
The superiority of EASS over conventional surgery remains unknown because of the
absence of controlled trials. The success of the procedure should not be overemphasized in
information for consent, and surgeons should be risk-averse. Well-designed studies based
on more patients are still required. The lack of ethical documentation indicates a high
degree of suspicion of the studies.
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